Crossmark

Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.102175

Published Print: 2026-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Yun, Byungyoon

Oh, Juyeon

Park, Heejoo https://orcid.org/0009-0006-5365-6435
Lee, Jian

Kim, Beom Kyung

Yoon, Jin-Ha
Funding

Funding for this research was provided by:

National Health Insurance Service (NHIS-2023-4-002)

Yonsei University College of Medicine (6-2024-0615)
License Information

Text and Data Mining valid from 2026-01-01

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2025-12-19
More Information

This article is maintained by: Elsevier

Article Title: Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.102175

Content Type: article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.